Cerulean Pharma IPO Research Information

Cerulean Pharma IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cerulean Pharma, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cerulean Pharma	CERU - NASDAQ	$11.00-$13.00	$7.00	$7.10	8.5 million	4/10/2014
Underwriter(s): Leerink Partners
Co-Manager(s): Canaccord Genuity, JMP Securities, Wedbush PacGrow Life Sciences
Industry: Health Care
Filing(s): Filed 2014-03-10 Terms Added 2014-03-31

Cerulean Pharma Quote & Chart - Click for current quote - CERU

About Cerulean Pharma (adapted from Cerulean Pharma prospectus):
They are a clinical-stage oncology-focused company applying our proprietary dynamic tumor targeting platform to develop differentiated therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CERU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.